Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Mediclin AG
XETRA:MED

Watchlist Manager
Mediclin AG Logo
Mediclin AG
XETRA:MED
Watchlist
Price: 3.8 EUR 2.7% Market Closed
Market Cap: €180.5m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
+8%
5Y
0%
10Y
+171%
Liabilities
+
3Y
+4%
5Y
-9%
10Y
+288%
Equity
+
3Y
+20%
5Y
+35%
10Y
+50%

Balance Sheet Decomposition
Mediclin AG

Balance Sheet
Mediclin AG

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
92
26
23
18
27
29
21
57
59
48
41
23
13
26
30
42
27
34
37
100
120
88
115
108
Cash Equivalents
92
26
23
18
27
29
21
57
59
48
41
23
13
26
30
42
27
34
37
100
120
88
115
108
Short-Term Investments
1
21
5
0
0
0
0
5
3
4
6
4
4
3
3
4
6
5
9
5
28
48
59
65
Total Receivables
50
50
65
67
52
51
56
64
58
66
61
62
64
65
72
75
88
101
110
88
98
102
94
114
Accounts Receivables
47
48
37
39
49
47
53
54
56
62
58
60
61
62
67
71
84
93
101
76
81
88
82
100
Other Receivables
3
2
28
28
3
4
3
10
2
4
3
2
3
3
5
3
4
8
9
11
16
13
13
15
Inventory
8
10
11
12
5
5
5
6
7
7
7
7
7
6
6
6
7
7
8
9
9
9
7
8
Other Current Assets
7
7
6
6
3
5
7
2
2
2
2
1
4
2
1
1
1
1
1
1
12
15
24
3
Total Current Assets
157
114
110
104
87
89
89
135
129
126
116
97
92
103
112
128
129
149
166
204
266
262
300
298
PP&E Net
161
217
211
204
121
121
129
146
147
150
155
162
159
156
161
162
178
195
617
572
508
544
514
533
PP&E Gross
161
217
211
204
121
121
129
146
147
150
155
162
159
156
161
162
178
195
617
572
508
544
514
533
Accumulated Depreciation
182
214
170
181
112
118
121
195
204
215
228
242
256
268
283
293
309
318
377
432
479
539
561
603
Intangible Assets
1
2
2
2
1
1
1
2
2
2
2
2
2
2
2
4
6
8
9
9
7
6
6
8
Goodwill
61
61
55
51
47
45
45
53
49
51
50
49
49
49
48
49
49
49
49
49
50
50
17
16
Note Receivable
0
0
0
0
0
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
1
1
1
0
0
0
0
0
0
0
0
2
2
2
1
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
1
1
1
2
13
11
5
7
7
7
6
7
9
5
5
5
7
45
56
53
50
55
43
50
Other Assets
61
61
55
51
47
45
45
53
49
51
50
49
49
49
48
49
49
49
49
49
50
50
17
16
Total Assets
381
N/A
395
+4%
379
-4%
361
-5%
269
-26%
268
0%
270
+1%
343
+27%
334
-3%
336
+1%
329
-2%
320
-3%
313
-2%
316
+1%
329
+4%
347
+5%
369
+6%
445
+21%
898
+102%
887
-1%
881
-1%
916
+4%
881
-4%
906
+3%
Liabilities
Accounts Payable
8
10
9
11
11
12
12
15
15
15
15
21
21
13
12
13
14
17
18
11
13
14
13
13
Accrued Liabilities
0
0
0
0
0
0
0
14
13
13
14
14
14
0
0
0
0
0
0
0
0
0
0
0
Short-Term Debt
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
37
23
42
2
1
7
68
75
71
71
72
9
7
7
7
11
16
21
71
81
82
50
51
28
Other Current Liabilities
38
40
63
46
49
36
32
21
20
20
9
7
9
33
38
36
35
50
57
79
119
106
108
125
Total Current Liabilities
84
74
114
58
61
55
112
124
119
120
109
50
51
53
56
59
65
88
146
171
213
171
171
166
Long-Term Debt
65
82
51
84
91
83
23
21
11
7
10
67
61
53
47
45
37
55
441
406
358
452
429
436
Deferred Income Tax
0
0
0
0
1
1
1
1
2
2
3
3
4
0
0
0
0
0
0
0
0
0
0
0
Minority Interest
1
2
2
3
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
96
120
115
136
29
28
28
48
44
42
42
42
45
55
57
61
81
110
120
133
127
83
84
81
Total Liabilities
246
N/A
278
+13%
282
+2%
282
0%
184
-35%
170
-8%
166
-3%
194
+17%
177
-9%
172
-3%
163
-5%
163
0%
161
-1%
161
+0%
160
-1%
165
+3%
183
+11%
253
+38%
707
+179%
710
+1%
698
-2%
707
+1%
685
-3%
683
0%
Equity
Common Stock
32
32
32
32
32
32
32
47
48
48
48
48
48
48
48
48
48
48
48
48
48
48
48
48
Retained Earnings
104
83
63
49
56
67
73
102
110
117
118
110
105
107
122
134
138
144
143
130
136
32
19
46
Additional Paid In Capital
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
129
129
129
Treasury Stock
0
3
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Equity
0
0
0
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Equity
135
N/A
117
-14%
97
-17%
80
-18%
85
+6%
98
+16%
104
+6%
149
+43%
157
+6%
165
+5%
166
+0%
157
-5%
152
-3%
154
+1%
169
+10%
182
+7%
186
+2%
192
+3%
191
0%
177
-7%
183
+3%
209
+14%
196
-6%
223
+14%
Total Liabilities & Equity
381
N/A
395
+4%
379
-4%
361
-5%
269
-26%
268
0%
270
+1%
343
+27%
334
-3%
336
+1%
329
-2%
320
-3%
313
-2%
316
+1%
329
+4%
347
+5%
369
+6%
445
+21%
898
+102%
887
-1%
881
-1%
916
+4%
881
-4%
906
+3%
Shares Outstanding
Common Shares Outstanding
32
32
32
32
30
32
32
47
48
48
48
48
48
48
48
48
48
48
48
48
48
48
48
48

See Also

Summary
MED intrinsic value, competitors valuation, and company profile.
DCF Valuation
MED stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MED stock valuation using valuation multiples.
Wall Street Estimates
MED price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MED stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 319,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.